9 /100
LOW RISK
Score updated Jul 13, 2026

ELV — Elevance Health, Inc. Dilution Risk Tracker

Track ELV dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ELV — Get alerts when the score changes →

As of July 13, 2026, Elevance Health, Inc. (ELV) has a DilutionWatch DilutionScore of 9/100, rated LOW dilution risk. Elevance Health, Inc. has a market capitalization of $85.39B, 217.16M shares outstanding, 1474 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
18
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ELV.
🔔 Track ELV — Get forecast alerts →

💹 Market Data

Market Cap$85.39B
Shares Outstanding217.16M
Float216.71M
Cash$9.66B
Debt$31.12B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 19.4% shares (2026Q1 vs prior)
1474 institutional holders · 253.04M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 28.69M shares
#2 BlackRock, Inc. 19.89M shares
#3 DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 11.35M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest6.01M
Days to Cover3.3
% of Float2.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2023
4 INSIDER TRANSACTION Mar 23, 2026
4 INSIDER TRANSACTION Mar 09, 2026
4 INSIDER TRANSACTION Mar 06, 2026
4 INSIDER TRANSACTION Mar 04, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for ELV Shareholders

Elevance Health, Inc. (ELV) has a DilutionScore of 9/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for ELV shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for ELV in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ELV alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track ELV Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ELV — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ELV
📊 ELV FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ELV Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.